“Anatomic Pathology Market Report is set to have rapid growth due rising implementation of tissue-diagnostic related procedures in disease screening and favourable reimbursement policies at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report
04 September 2019
Visiongain has launched a new pharma report Anatomic Pathology Market Forecast 2019-2029: By Application (Disease Diagnosis, Drug Discovery & Development), By Product & Services (Instruments, Consumables), By End Use, And Segment Forecasts.
The global Anatomic Pathology market is poised for rapid growth between 2019 and 2029. The increase in the incidence of chronic diseases, advances in technology and the increase in the geriatric population are some of the key factors driving market growth.
Advances in technology have witnessed the anatomical pathology market. For example, in November 2018, Greg Clark, business secretary of the UK government, announced that the consortium groups will gather to create five new pathology and digital imaging centers, using artificial intelligence to accelerate the diagnosis of diseases in the United Kingdom, bringing together representatives of various divisions of the sector.
Companies are making continuous efforts to develop advanced and up-to-date pathological equipment with regards to their design and ease of use. Furthermore, there have been several collaborations and agreements between key companies for the introduction of an effective portfolio in order to circumvent the challenges related to disease management.
Leading companies featured in the report include Thermo Fisher Scientific, Inc.; Cardinal Health, Inc.; F. Hoffmann-La Roche AG; Agilent Technologies, Inc.; Sakura Finetek USA, Inc.; Quest Diagnostics Incorporated; Laboratory Corporation of America Holdings; NeoGenomics Laboratories, Inc.; BioGenex; and Bio SB.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
As lockdowns were imposed in all the countries, diagnosis rates went down in majority of countries during the year hitting the drug sales for some period. Although lockdown measures have been eased up in most countries by mid-year 2020, this trend is expected to continue beyond 2020, stock up of medicines by patients is likely to propel the drug sales in majority of the developed economies, which account for majority of rare diseases.
02 March 2021
Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.
26 February 2021
The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.
22 February 2021
The global Big Data Analytics in Healthcare market has been growing considerably owing to the rising technological advancement, growing investment, and cohesive government policies.